Post-MI angina linked to increased late readmission risk
US researchers are calling for greater surveillance and treatment of post-myocardial infarction angina after their findings show an increased risk of late readmission among patients with angina symptoms at 30 days. (Source: MedWire News)
Source: MedWire News - June 17, 2016 Category: Consumer Health News Tags: Acute coronary syndromes Source Type: news

Overweight in adolescence portends early heart failure
medwireNews: A study of Swedish army conscripts shows that men who have an increased body mass index (BMI) at the age of 18 years risk early heart failure. And the increased risk began at a BMI gener ... (Source: MedWire News)
Source: MedWire News - June 17, 2016 Category: Consumer Health News Tags: Heart failure Source Type: news

Best diabetic macular oedema drugs ‘not cost-effective’
Resource utilisation data from the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial show that the most efficacious drug for diabetic macular oedema, aflibercept, is not cost-effective relative to repackaged bevacizumab. (Source: MedWire News)
Source: MedWire News - June 17, 2016 Category: Consumer Health News Tags: Diabetes Source Type: news

Cabozantinib extends advanced RCC overall survival
Patients with advanced or metastatic renal cell carcinoma derive a significant overall survival benefit from second-line treatment with the multi-tyrosine kinase inhibitor cabozantinib relative to everolimus. (Source: MedWire News)
Source: MedWire News - June 17, 2016 Category: Consumer Health News Tags: Kidney cancer Source Type: news

Sleep-disordered breathing increases cardiovascular risk in ACS patients
Sleep-disordered breathing is an important risk factor for major adverse cardiocerebrovascular events among patients with acute coronary syndromes, Japanese research shows. (Source: MedWire News)
Source: MedWire News - June 17, 2016 Category: Consumer Health News Tags: Acute coronary syndromes Source Type: news

Worsening renal function linked to increased cardiovascular risk in AF
Patients with atrial fibrillation and declining renal function are at increased risk of subsequent stroke or systemic embolism, major bleeding and death, US researchers report. (Source: MedWire News)
Source: MedWire News - June 17, 2016 Category: Consumer Health News Tags: Arrhythmia Source Type: news

Global stroke burden largely due to preventable risk factors
More than 90% of the global stroke burden is attributable to modifiable risk factors and with behavioural and metabolic risk factors making the greatest contribution, controlling these could avert more than three-quarters of this burden. (Source: MedWire News)
Source: MedWire News - June 16, 2016 Category: Consumer Health News Tags: Stroke Source Type: news

Salvage alloSCT remains option for progressing CML patients
Research demonstrates the continuing role of allogeneic stem cell transplantation as a salvage option for patients with chronic myeloid leukaemia who progress to accelerated phase or blast crisis after tyrosine kinase inhibitor failure. (Source: MedWire News)
Source: MedWire News - June 15, 2016 Category: Consumer Health News Tags: Chronic myeloid leukaemia Source Type: news

Potential non-invasive screening biomarker for SSc-PAH
Serum asymmetric dimethylarginine may be an effective non-invasive screening biomarker for systemic sclerosis-related pulmonary arterial hypertension, study findings indicate. (Source: MedWire News)
Source: MedWire News - June 15, 2016 Category: Consumer Health News Tags: Pulmonary hypertension Source Type: news

Empagliflozin offers long-term renal protection in Type 2 diabetes
The sodium–glucose cotransporter 2 inhibitor empagliflozin slows renal progression and averts clinical events, shows further analysis of the EMPA-REG OUTCOME trial. (Source: MedWire News)
Source: MedWire News - June 15, 2016 Category: Consumer Health News Tags: Diabetes Source Type: news

Cerebral vessel disease increases Alzheimer’s dementia risk
Cerebral vessel disease may be an under-recognised risk factor for Alzheimer’s disease dementia, say researchers. (Source: MedWire News)
Source: MedWire News - June 15, 2016 Category: Consumer Health News Tags: Alzheimer ' s disease Source Type: news

‘Nonserious’ side effects may lead to antiplatelet discontinuation
Most adverse events that lead patients to discontinue antiplatelet drugs are not rated as serious by clinical trial criteria, shows analysis of the PEGASUS-TIMI 54 trial. (Source: MedWire News)
Source: MedWire News - June 15, 2016 Category: Consumer Health News Tags: Cardiology Source Type: news

Risk factors differ for early and delayed dementia after ICH
Acute haematoma parameters predict the onset of dementia in the first 6 months after intracerebral haemorrhage, but not that of delayed dementia, report researchers. (Source: MedWire News)
Source: MedWire News - June 15, 2016 Category: Consumer Health News Tags: Stroke Source Type: news

Long-term dasatinib findings support first-line use in CML
Final DASISION study findings confirm dasatinib to be an effective, long-term treatment for patients with a new diagnosis of chronic phase–chronic myeloid leukaemia. (Source: MedWire News)
Source: MedWire News - June 15, 2016 Category: Consumer Health News Tags: Chronic myeloid leukaemia Source Type: news

Maintenance TKI therapy ‘feasible’ for high-risk CML patients after allogeneic HSCT
Patients with high-risk chronic myeloid leukaemia who undergo allogeneic haematopoietic stem cell transplantation may benefit from continuing with tyrosine kinase inhibitor therapy, US clinicians believe. (Source: MedWire News)
Source: MedWire News - June 15, 2016 Category: Consumer Health News Tags: Chronic myeloid leukaemia Source Type: news